Skip to main content

Chemotherapy Usually Intended for Dogs is Treating a Red Fox’s Lymphoma

Purdue Veterinary Hospital and Wolf Park Collaborate to Treat an Unusual Patient

Chris sits beside Joker the fox holding out his hand as Joker stands on a log looking up at him
The most rewarding part of Joker’s treatment, for Dr. Chris Fulkerson, has been seeing his tumors responding and watching him live his life as normal. (Purdue University photo/John Underwood)

The Purdue University Veterinary Hospital works with many patients across species. None are more unusual perhaps than Joker, an eight-year-old silver-phased red fox undergoing treatment for lymphoma. Joker resides at Wolf Park, a nonprofit conservation facility located in nearby Battle Ground, Ind.

During a routine medical check in November, his handler, Kimber Hendrix, noticed small tumors on his tongue.  Wolf Park’s veterinarian, Dr. Julia Becker, sent a biopsy to the Animal Disease Diagnostic Laboratory at the Purdue University College of Veterinary Medicine, where Joker was diagnosed with T-cell lymphoma by Dr. Mario Sola, assistant professor of diagnostic pathology.  Dr. Becker then referred Joker’s case to Dr. Christopher Fulkerson, clinical assistant professor of veterinary medical oncology in the College of Veterinary Medicine. 

Dr. Fulkerson hadn’t previously worked with a fox patient. He and his team couldn’t find any literature about this type of lymphoma in foxes, so they are treating Joker based on a protocol often used for dogs with lymphoma. This chemotherapy protocol mainly uses chemotherapy pills, which the team thought was most likely to be well-tolerated and successful.

According to Dr. Fulkerson, Joker’s behavior is similar to that of a dog. He is as wild as possible at Wolf Park, but is social and trained for medical procedures. “He’s a really laid-back fox,” Hendrix said. “He’s a sweet guy to work with. He’s a great animal ambassador.”

Joker has been at Wolf Park since 2015, when he was rescued after being found under a porch. His laid back personality – accompanied with a knack of playing practical jokes on his den mate Scarlette – make him a favorite among visitors.

Chris wears a mask outside at Wolf Park as he holds out an egg that Joker the fox puts in his mouth
After a treatment at Wolf Park, Dr. Chris Fulkerson rewards Joker with his favorite treat: an egg. (Purdue University photo/John Underwood)

To minimize his stress and anxiety, as many procedures as possible are followed at Wolf Park. Since January, Dr. Fulkerson has been going to Wolf Park almost weekly to administer Joker’s treatment and check his laboratory reports. On these days, Joker is rewarded with a special treat: an egg.

Joker is responding well to chemotherapy. After a few weeks of treatment, his lymphoma is in partial remission, meaning most of the lesions have gone away or have substantially decreased in size. He is undergoing chemotherapy treatments until mid-April. The hope is that over time, complete remission is achieved with the disappearance of all lesions, although the treatment time frame may be extended if lesions remain.

“We follow his lab work really closely to make sure that the chemotherapy drugs aren’t having any adverse effects on his white blood cell count. This drug can also cause liver injury, so we monitor his liver function and liver values. That all has been good throughout all the treatment, with no signs of obvious chemotherapy side effects,” Dr. Fulkerson said.

In captivity, red foxes can live 12-14 years. Each day, Joker engages in training and enrichment with staff and volunteers, and he has plenty of energy to play with his enrichment objects. Hendrix said that even during treatment, he hasn’t had any bad days.

Dr. Fulkerson said that the most gratifying and exciting part of Joker’s treatment has been seeing his tumors responding and seeing him living his life as normal.

“I was wearing my mask because of COVID-19,” he said of a recent visit, “But I told his handlers if they could have seen my face under it, I probably had one of the biggest smiles I’d had in the last year just from seeing him frolicking around and being excited and happy.”

Dr. Fulkerson treats Joker the fox as his handler holds him on an exam table in the Purdue University Veterinary Hospital
Dr. Chris Fulkerson, clinical assistant professor of veterinary medical oncology, treats Joker, a silver-phased red fox, at the Purdue University Veterinary Hospital. (Purdue University photo/John Underwood)

Purdue has offset the cost of some of Joker’s procedures with teaching funds. Joker’s lymphoma already has been a good learning case for diagnostic imaging, oncology, and pathology.  Following Joker’s progress may help with treatment of similar cases in the future.

The remaining costs, as of now, have been fully funded through donations to Wolf Park, although more need may arise in the future if his treatment is extended.

Hendrix said she’s thankful that Wolf Park has been able to partner with Purdue on Joker’s treatment.

“I just really have loved the partnership that has blossomed between Wolf Park and Purdue throughout this,” she said. “I’d love for there to be something that comes out of this to help other exotics so that people learn more about the progression of the disease, can help other animals in human care and can do more for them. Anything that can be learned from his case would be wonderful.”

Dr. Fulkerson agrees. He and his team plan to compile a case report on Joker so that this treatment option is documented to help other foxes diagnosed with lymphoma in the future.

“One of the great things about being at Purdue and being an academic veterinarian is that we can see some of these unusual things, we have some resources we can bring to help us learn about them, and then we can share that information with other veterinarians to help other patients in the future,” he said.

Click here to view a full Purdue news release.

Writer(s): Kelsey Lefever, Purdue Marketing and Communications | pvmnews@purdue.edu

Recent Stories

Indiana FFA Names PVM’s Julia Wickard as One of Five New Board Members

Executive Director of the Purdue Veterinary Alumni Association and Constituent Liaison Julia Wickard is one of five newly named members of the Indiana FFA Foundation board of directors.  The appointments took effect July 1.

Alumnus and Oncology Specialist Dr. Christopher Fulkerson Appointed as Associate Dean for Purdue Veterinary Hospitals

Purdue Veterinary Medicine Dean Bret D. Marsh, DVM, has named Dr. Christopher Fulkerson as Associate Dean for Clinical Affairs and Chief Veterinary Officer for the Purdue Veterinary Hospitals. The appointment was announced July 1, the same day that Dr. Fulkerson’s promotion to full Clinical Professor of Veterinary Medical Oncology took effect.

“Paws Up” for the ADDL Accessioning and Molecular Teams – brought to you by the PVM Wellness Committee

This week, we express our sincere gratitude to our ADDL Accessioning and Molecular Teams (and cross trained individuals).

PVM Dean Bret Marsh Shares College Update with Swine Producers and Industry Partners at Major Swine Event in Indianapolis

Swine Health was the focus of a significant event recently at the Indiana State Fairgrounds in Indianapolis as swine industry partners and swine producers gathered for the National Junior Summer Spectacular (NJSS) and Summer Type Conference (STC).  The event was held at the end of June in the Fall Creek Pavillion and included a Swine Health Briefing that featured swine industry and veterinary medicine leaders including Purdue Veterinary Medicine Dean Bret Marsh, who also had an opportunity to provide an update on the College of Veterinary Medicine.

2026 Annual Recognition Ceremony Honors VCS Residents, Graduate Students, and PVH Interns

On Monday, June 29, 2026, more than 100 faculty and staff from the Department of Veterinary Clinical Sciences and the Purdue University Veterinary Hospital gathered at Thomas Duncan Hall for the 2026 Resident and Intern Recognition Ceremony. This annual event provides a great opportunity to honor and celebrate the contributions of the residents, interns, and graduate students who are completing their programs this summer.

New Administrative Assistant Joins PVM Office of Student Success

The Purdue University College of Veterinary Medicine welcomes Charity Holden as the new administrative assistant in the Office of Student Success.

“Paws Up” for Scott Fix – brought to you by the PVM Wellness Committee

This week we are highlighting Scott Fix who is the Lead Facilities Manager in the Department of Veterinary Administration.

Remembering Zeus: A Legacy of Loyalty and Love

We continue our series of articles about animals and their owners who’ve found help and healing at the Purdue University Veterinary Hospital by sharing the story of a beloved dog named Zeus. For Amy Fitzsimmons-Blaising, Zeus wasn’t just a dog, he was her spirit animal and best friend. A proud Giant Schnauzer bred in Bedford, Indiana, Zeus had been the heart of Amy’s home for 11 unforgettable years. Then, in October 2024, Zeus’s health challenges began, when he started coughing and showing signs that looked like seizures. After rushing him to a local veterinary urgent care facility, Amy learned he was in congestive heart failure, and she turned to the Purdue University Veterinary Hospital for help.

PVM Scholar Receives Purdue WGHI Pilot Grant Aimed at Advancing Women’s Health

Purdue University’s Women’s Global Health Institute (WGHI) has announced six pilot research grant awards aimed at solving critical problems in women’s health and quality of life, and one of recipients is Purdue Veterinary Medicine faculty member Viju Vijayan Pillai. Dr. Pillai is assistant professor of anatomic pathology in the College of Veterinary Medicine’s Department of Comparative Pathobiology.

The universal socket set of vaccines: Innovative technology heralds more effective, more efficient vaccines

You fight fire with fire. And Purdue Veterinary Medicine vaccine expert Suresh Mittal fights viruses with viruses. Using innovative techniques, Dr. Mittal, Distinguished Professor of Virology in the College of Veterinary Medicine’s Department of Comparative Pathobiology, develops novel vaccines for viral infections including avian influenza.